用F-flurpiridaz PET进行心肌 perfusion 成像的诊断性能与总 perfusion 缺陷量化
Jennifer M Renaud1, Jonathan B Moody1, Michael D Vanderver1
1INVIA Medical Imaging Solutions, Ann Arbor, MI, USA.
概括
使用flurpiridaz的自动总 perfusion deficit (TPD) 呈现出可比的诊断准确性与检测冠状动脉疾病的视觉评估. 该方法提供了可靠的全球和区域疾病范围和严重程度的评估.
科学领域:
- 心血管成像 - 心血管成像
- 核心脏病学 核心脏病学
- 放射性药物 放射性药物 放射性药物
背景情况:
- 冠状动脉疾病 (CAD) 的诊断依赖于精确的心肌输液成像 (MPI).
- 传统的MPI视觉评估可能是主观的.
- 自动化指标为客观CAD评估提供了潜力.
研究的目的:
- 为了评估F-flupiridaz正子发射断层扫描 (PET) MPI用于CAD检测的诊断性能.
- 评估总 perfusion deficit (TPD) 的实用性,这是一个自动化指标,用于量化疾病的综合程度和严重程度.
主要方法:
- 分析了Flurpiridaz PET MPI和定量冠状动脉血管学数据.
- 使用接收器操作特征分析来确定在≥70%和≥50%的狭窄值下诊断性能.
- 对TPD的表现进行了比较,以视觉评分和缺陷程度从先前的研究在每患者和每容器的水平.
主要成果:
- 自动TPD在≥70%的狭窄时显示出74%的准确性,可与视觉评分 (75%) 和缺陷程度 (72%) 相比.
- 在每艘船的层面上,TPD对LAD和LCx的缺陷程度表现出类似的准确性,对RCA的准确性略高.
- 在≥50%的狭窄终点观察到类似的诊断性能.
结论:
- 使用flurpiridaz PET MPI的自动TPD提供了与视觉评分和缺陷程度量化可比的诊断性能.
- 在CAD检测中,TPD代表了一种可靠的自动化工具,用于评估全球和区域心肌输液.
更多相关视频
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
19.7K
11:09High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
Published on: December 16, 2022
3.9K
相关概念视频
Assessment of Diffusion and Perfusion
1.1K
Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
1.1K
Positron Emission Tomography
5.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
5.9K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
241
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
241
![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg&w=3840&q=50)